![Hans G. Nilsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans G.
Nilsson is currently the Director at PharmNovo AB since 2018.
Prior to this, he was the President at AstraZeneca R&D Boston, Inc.
| Sociétés | Poste | Début |
|---|---|---|
PharmNovo AB
 PharmNovo AB Miscellaneous Commercial ServicesCommercial Services Operates as an biotechnology company | Directeur/Membre du Conseil | 01/01/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca R&D Boston, Inc.
 AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
AstraZeneca R&D Boston, Inc.
AstraZeneca R&D Boston, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets prescription pharmaceutical drugs | Health Technology |
PharmNovo AB
PharmNovo AB Miscellaneous Commercial ServicesCommercial Services Operates as an biotechnology company | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
